The prognosis in systemic lupus erythematosus (SLE) has improved due to better treatment
and care, but cardiovascular disease (CVD) still remains an important clinical problem, since …

Atherosclerosis is an inflammatory disease and the major cause of cardiovascular disease
(CVD) in general. Atherosclerotic plaques are characterized by the presence of activated …

Over the past number of years numerous data have been published regarding increased
atherosclerosis in patients with systemic lupus erythematosus (SLE), and it has been shown …

Atherosclerosis is a chronic inflammatory disorder characterized by immune cell activation,
inflammation driven plaque formation and subsequent destabilization. In other disorders of …

Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease that has a late
mortality phase owing mainly to cardiovascular manifestations. Atherosclerosis itself is …

Patients with systemic lupus erythematosus (SLE) have a significantly increased risk of
cardiovascular disease (CVD). Increased prevalence of atherosclerosis may explain part of …

Systemic lupus erythematosus (SLE) is a chronic and multisystemic autoimmune disorder
which predominantly affecting women. The most common cause of death in SLE patients …

Atherosclerosis is an inflammatory disease characterised by presence of activated immune
competent cells in middle-sized and large arteries and is the major cause of cardiovascular …

Systemic lupus erythematosus (SLE) is an autoimmune disorder that primarily affects young
women and is characterized by inflammation in several organs including kidneys, skin …

Objective Although antiphospholipid antibodies (aPL) are associated with arterial and
venous thrombosis in systemic lupus erythematosus (SLE), the extent to which they …